Kymera Therapeutics to Participate in Upcoming November Investor Conferences
Kymera Therapeutics (NASDAQ: KYMR) has announced its participation in several major healthcare investor conferences this November. The company will engage in fireside chats at the Guggenheim Inaugural Healthcare Innovation Conference in Boston, Stifel 2024 Healthcare Conference in New York, Wolfe Research Healthcare Conference in New York, and Jefferies London Healthcare Conference in London. Additionally, they will attend the J.P. Morgan Equity Opportunities Forum in Miami for one-on-one meetings. Live webcasts of the presentations will be available on the company's website under the Investors section, with replays accessible after the events.
Kymera Therapeutics (NASDAQ: KYMR) ha annunciato la sua partecipazione a diverse importanti conferenze per investitori nel settore sanitario questo novembre. L'azienda parteciperà a conversazioni informali al Guggenheim Inaugural Healthcare Innovation Conference a Boston, al Stifel 2024 Healthcare Conference a New York, al Wolfe Research Healthcare Conference a New York e al Jefferies London Healthcare Conference a Londra. Inoltre, parteciperanno al J.P. Morgan Equity Opportunities Forum a Miami per incontri faccia a faccia. Le trasmissioni in diretta delle presentazioni saranno disponibili sul sito web dell'azienda nella sezione Investitori, con riproduzioni accessibili dopo gli eventi.
Kymera Therapeutics (NASDAQ: KYMR) ha anunciado su participación en varias conferencias importantes para inversores en el área de salud este noviembre. La compañía participará en charlas informales en la Guggenheim Inaugural Healthcare Innovation Conference en Boston, en la Stifel 2024 Healthcare Conference en Nueva York, en la Wolfe Research Healthcare Conference en Nueva York y en la Jefferies London Healthcare Conference en Londres. Adicionalmente, asistirán al J.P. Morgan Equity Opportunities Forum en Miami para reuniones uno a uno. Las transmisiones en vivo de las presentaciones estarán disponibles en el sitio web de la compañía en la sección de Inversores, con repeticiones accesibles después de los eventos.
Kymera Therapeutics (NASDAQ: KYMR)는 이번 11월에 여러 주요 의료 투자자 컨퍼런스에 참석할 것이라고 발표했습니다. 회사는 보스턴의 Guggenheim Inaugural Healthcare Innovation Conference, 뉴욕의 Stifel 2024 Healthcare Conference, 뉴욕의 Wolfe Research Healthcare Conference 및 런던의 Jefferies London Healthcare Conference에서 대화에 참여할 예정입니다. 또한, 마이애미에서 J.P. Morgan Equity Opportunities Forum에 참석하여 일대일 미팅을 가질 것입니다. 프레젠테이션의 실시간 웹 방송은 회사의 웹사이트의 투자자 섹션에서 제공되며, 이벤트 후에는 재생이 가능합니다.
Kymera Therapeutics (NASDAQ: KYMR) a annoncé sa participation à plusieurs grandes conférences d'investisseurs dans le secteur de la santé ce mois de novembre. L'entreprise participera à des discussions informelles lors de la Guggenheim Inaugural Healthcare Innovation Conference à Boston, de la Stifel 2024 Healthcare Conference à New York, de la Wolfe Research Healthcare Conference à New York et de la Jefferies London Healthcare Conference à Londres. De plus, ils assisteront au J.P. Morgan Equity Opportunities Forum à Miami pour des réunions en tête-à-tête. Les diffusions en direct des présentations seront disponibles sur le site web de l'entreprise dans la section Investisseurs, avec des rediffusions accessibles après les événements.
Kymera Therapeutics (NASDAQ: KYMR) hat seine Teilnahme an mehreren bedeutenden Gesundheitsinvestorenkonferenzen im November angekündigt. Das Unternehmen wird an informellen Gesprächen auf der Guggenheim Inaugural Healthcare Innovation Conference in Boston, der Stifel 2024 Healthcare Conference in New York, der Wolfe Research Healthcare Conference in New York und der Jefferies London Healthcare Conference in London teilnehmen. Zudem werden sie am J.P. Morgan Equity Opportunities Forum in Miami für persönliche Gespräche teilnehmen. Die Live-Übertragungen der Präsentationen sind auf der Website des Unternehmens im Bereich Investoren verfügbar, mit Wiederholungen, die nach den Veranstaltungen zugänglich sind.
- None.
- None.
WATERTOWN, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events:
- Guggenheim Inaugural Healthcare Innovation Conference in Boston, MA on November 12 at 10:00 a.m. ET;
- J.P. Morgan Equity Opportunities Forum in Miami, FL on November 14, one-on-one meetings only;
- Stifel 2024 Healthcare Conference in New York, NY on November 18 at 11:30 a.m. ET;
- 6th Annual Wolfe Research Healthcare Conference in New York, NY on November 19 at 9:20 a.m. ET; and
- Jefferies London Healthcare Conference in London, UK on November 20 at 4:00 p.m. GMT.
Live webcasts of the presentations will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. Replays of the webcasts will be archived and available following the events.
About Kymera Therapeutics
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X or LinkedIn.
Investor and Media Contact:
Justine Koenigsberg
Vice President, Investor Relations
investors@kymeratx.com
media@kymeratx.com
857-285-5300
FAQ
What investor conferences is Kymera Therapeutics (KYMR) attending in November 2024?
Where can I watch Kymera Therapeutics (KYMR) November 2024 conference presentations?
What time is Kymera Therapeutics (KYMR) presenting at the Guggenheim Healthcare Conference?
Will Kymera Therapeutics (KYMR) be presenting at the J.P. Morgan Forum in November 2024?
